IBDEI1FB ; ; 12-AUG-2014
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 15, 2014
 Q:'DIFQR(358.4)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.4)
 ;;=^IBE(358.4,
 ;;^UTILITY(U,$J,358.4,0)
 ;;=IMP/EXP SELECTION GROUP^358.4I^1674^1674
 ;;^UTILITY(U,$J,358.4,1,0)
 ;;=SUBSTANCE ABUSE^4^1
 ;;^UTILITY(U,$J,358.4,2,0)
 ;;=DIAGNOSTIC EVALUATION^1^1
 ;;^UTILITY(U,$J,358.4,3,0)
 ;;=PSYCHOTHERAPY ^2^1
 ;;^UTILITY(U,$J,358.4,4,0)
 ;;=OTHER CODES^3^1
 ;;^UTILITY(U,$J,358.4,5,0)
 ;;=TOBACCO CESSATION^5^1
 ;;^UTILITY(U,$J,358.4,6,0)
 ;;=ADJUSTMENT DISORDERS^2^2
 ;;^UTILITY(U,$J,358.4,7,0)
 ;;=ANXIETY DISORDERS^4^2
 ;;^UTILITY(U,$J,358.4,8,0)
 ;;=AMNESTICS^3^2
 ;;^UTILITY(U,$J,358.4,9,0)
 ;;=ORGANIC DISORDERS^13^2
 ;;^UTILITY(U,$J,358.4,10,0)
 ;;=DEMENTIA^8^2
 ;;^UTILITY(U,$J,358.4,11,0)
 ;;=DELIRIUM^7^2
 ;;^UTILITY(U,$J,358.4,12,0)
 ;;=BIPOLAR DISORDERS^5^2
 ;;^UTILITY(U,$J,358.4,13,0)
 ;;=PSYCHOSIS/OTHER^17^2
 ;;^UTILITY(U,$J,358.4,14,0)
 ;;=PERSONALITY DISORDERS^15^2
 ;;^UTILITY(U,$J,358.4,15,0)
 ;;=SEXUAL DISORDERS^19^2
 ;;^UTILITY(U,$J,358.4,16,0)
 ;;=SLEEP DISORDERS^20^2
 ;;^UTILITY(U,$J,358.4,17,0)
 ;;=OTHER DISORDERS^14^2
 ;;^UTILITY(U,$J,358.4,18,0)
 ;;=SUBSTANCE RELATED DISORDERS^22^2
 ;;^UTILITY(U,$J,358.4,19,0)
 ;;=V CODES^23^2
 ;;^UTILITY(U,$J,358.4,20,0)
 ;;=PREVENTION/COUNSELING/SCREEN^16^2
 ;;^UTILITY(U,$J,358.4,21,0)
 ;;=DEPRESSION^9^2
 ;;^UTILITY(U,$J,358.4,22,0)
 ;;=MOOD DISORDERS (OTHER)^11^2
 ;;^UTILITY(U,$J,358.4,23,0)
 ;;=SCHIZOPHRENIA^18^2
 ;;^UTILITY(U,$J,358.4,24,0)
 ;;=SOMATIFORM DISORDERS^21^2
 ;;^UTILITY(U,$J,358.4,25,0)
 ;;=EATING DISORDERS^10^2
 ;;^UTILITY(U,$J,358.4,26,0)
 ;;=NEUROLEPTIC-INDUCED MOVEMENT DISORD^12^2
 ;;^UTILITY(U,$J,358.4,27,0)
 ;;=CONTACT W/ HAZARDOUS SUBSTANCES^1^2
 ;;^UTILITY(U,$J,358.4,28,0)
 ;;=BRAIN DISORDERS^6^2
 ;;^UTILITY(U,$J,358.4,29,0)
 ;;=ESTABLISHED PATIENT^1^3
 ;;^UTILITY(U,$J,358.4,30,0)
 ;;=CONSULTATIONS^3^3
 ;;^UTILITY(U,$J,358.4,31,0)
 ;;=NEW PATIENT^2^3
 ;;^UTILITY(U,$J,358.4,32,0)
 ;;=INPATIENT CONSULTATIONS^4^3
 ;;^UTILITY(U,$J,358.4,33,0)
 ;;=INITIAL HOSPITAL CARE^5^3
 ;;^UTILITY(U,$J,358.4,34,0)
 ;;=HOSPITAL CARE DISCHARGE SERVICES^7^3
 ;;^UTILITY(U,$J,358.4,35,0)
 ;;=INITIAL OBSERVATION CARE^8^3
 ;;^UTILITY(U,$J,358.4,36,0)
 ;;=OBSERVATION CARE DISCHARGE SERVICES^10^3
 ;;^UTILITY(U,$J,358.4,37,0)
 ;;=INPT/OBS ADMIT/DISCHARGE SAME DATE^11^3
 ;;^UTILITY(U,$J,358.4,38,0)
 ;;=SUBSEQUENT HOSPITAL CARE^6^3
 ;;^UTILITY(U,$J,358.4,39,0)
 ;;=OBSERVATION SUBSEQUENT CARE^9^3
 ;;^UTILITY(U,$J,358.4,40,0)
 ;;=DOMICILLIARY CARE-ESTAB PATIENT^12^3
 ;;^UTILITY(U,$J,358.4,41,0)
 ;;=DOMICILLIARY CARE-NEW PATIENT^13^3
 ;;^UTILITY(U,$J,358.4,42,0)
 ;;=NEW PATIENT^2^4
 ;;^UTILITY(U,$J,358.4,43,0)
 ;;=ESTABLISHED PATIENT^1^4
 ;;^UTILITY(U,$J,358.4,44,0)
 ;;=CONSULTATIONS^3^4
 ;;^UTILITY(U,$J,358.4,45,0)
 ;;=ALLERGY DIAGNOSES^1^5
 ;;^UTILITY(U,$J,358.4,46,0)
 ;;=OTHER^3^5
 ;;^UTILITY(U,$J,358.4,47,0)
 ;;=IMMUNODEFICIENCY^2^5
 ;;^UTILITY(U,$J,358.4,48,0)
 ;;=IMMUNIZATION^4^6
 ;;^UTILITY(U,$J,358.4,49,0)
 ;;=SKIN TEST^9^6
 ;;^UTILITY(U,$J,358.4,50,0)
 ;;=ALLERGENIC EXTRACT^1^6
 ;;^UTILITY(U,$J,358.4,51,0)
 ;;=PATCH TESTS^8^6
 ;;^UTILITY(U,$J,358.4,52,0)
 ;;=ALLERGY INJECTION/EXTRACT^2^6
 ;;^UTILITY(U,$J,358.4,53,0)
 ;;=LABORATORY^6^6
 ;;^UTILITY(U,$J,358.4,54,0)
 ;;=INFUSIONS^5^6
 ;;^UTILITY(U,$J,358.4,55,0)
 ;;=OTHER^7^6
 ;;^UTILITY(U,$J,358.4,56,0)
 ;;=PRE-OP VISIT^1^7
 ;;^UTILITY(U,$J,358.4,57,0)
 ;;=CONSULTATION-CLINICIAN^2^7
 ;;^UTILITY(U,$J,358.4,58,0)
 ;;=POST-OP VISIT^3^7
 ;;^UTILITY(U,$J,358.4,59,0)
 ;;=NERVE BLOCK^12^8
 ;;^UTILITY(U,$J,358.4,60,0)
 ;;=CATH^2^8
 ;;^UTILITY(U,$J,358.4,61,0)
 ;;=CVA DEVICE^3^8
 ;;^UTILITY(U,$J,358.4,62,0)
 ;;=EPIDURAL^4^8
 ;;^UTILITY(U,$J,358.4,63,0)
 ;;=FOREARM/WRIST/HAND^5^8
